Protalix, Chiesi challenge Sanofi with EU approval for Fabry disease med as FDA decision looms kdunleavy Fri, 05/05/2023 – 14:13 More: Protalix, Chiesi challenge Sanofi with EU approval for Fabry disease med as FDA decision looms Source: fierce
read moreBiogen chalks up a Tecfidera patent win in Europe after losing US protections zbecker Fri, 05/05/2023 – 10:45 More: Biogen chalks up a Tecfidera patent win in Europe after losing US protections Source: fierce
read moreAfter FDA rejection, Gilead’s Hepcludex looks set for full EU nod kdunleavy Fri, 05/05/2023 – 09:45 More: After FDA rejection, Gilead's Hepcludex looks set for full EU nod Source: fierce
read moreFibroGen’s roxadustat fails in 2nd act, endangering AstraZeneca partnership aliu Fri, 05/05/2023 – 09:13 More: FibroGen's roxadustat fails in 2nd act, endangering AstraZeneca partnership Source: fierce
read moreThe vital recommendation ensures marketing authorisation for treating the hepatitis delta virus More: Positive opinion for Gilead’s Hepcludex Source: News
read moreSystems will support millions of patients with chronic respiratory conditions throughout Europe More: Kry showcases digital care pathways Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals